<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35369881</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1752-1947</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>04</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of medical case reports</Title>
          <ISOAbbreviation>J Med Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Overlapping rheumatoid arthritis and antisynthetase syndrome with secondary Sjögren's syndrome: a case report and review of the literature.</ArticleTitle>
        <Pagination>
          <StartPage>132</StartPage>
          <MedlinePgn>132</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">132</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13256-022-03353-3</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Overlap syndromes account for about 25% of autoimmune diseases. They are many possible combinations of known autoimmune diseases increasingly diagnosed with the identification of of a large number of autoantibodies. In this case report, we present a patient with rare overlapping rheumatoid arthritis-antisynthetase syndrome with associated secondary Sjögren's syndrome atypically presenting without interstitial lung disease.</AbstractText>
          <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A 52-year-old Sinhalese female, a known patient with type 2 diabetes mellitus, presented with a history of symmetrical inflammatory-type polyarthritis with significant morning stiffness, proximal muscle weakness, pain, and roughening of the fingertips with associated sicca symptoms of 5 months duration. Examination revealed features of active joint inflammation, mechanic's hand, xerostomia, and left-sided breast lump. Investigations confirmed the presence of rheumatoid arthritis with strongly positive rheumatoid factor (202 U/ml) and anti-cyclic citrullinated peptide antibody (717 U/ml). Antisynthetase syndrome was also diagnosed with borderline-positive anti-aminoacyl-tRNA antibodies but without interstitial lung disease. Sjögren's syndrome was confirmed by the clinical history and histology and considered a secondary disorder. As her breast lump proved to be benign, no further interventions were done. She was started on sulfasalazine and methotrexate with steroid bridging therapy and achieved remission and had good control of the disease without any joint deformity or flare-up on 6-month clinic follow-up.</AbstractText>
          <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Overlapping rheumatoid arthritis-antisynthetase syndrome is a very rare disease with disabling complications. Early identification of the atypical presentations of the overlap syndromes, by thorough investigations, helps physicians to prescribe proper disease-modifying antirheumatoid drugs and biological drugs. It also helps predict the prognosis of the patients before they develop complications.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Weerasinghe</LastName>
            <ForeName>W S</ForeName>
            <Initials>WS</Initials>
            <Identifier Source="ORCID">0000-0002-0041-2350</Identifier>
            <AffiliationInfo>
              <Affiliation>Teaching Hospital, Peradeniya, Sri Lanka. sunethws@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jayasinghe</LastName>
            <ForeName>Chandrika</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Faculty of Medicine, Peradeniya, Sri Lanka.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Med Case Rep</MedlineTA>
        <NlmUniqueID>101293382</NlmUniqueID>
        <ISSNLinking>1752-1947</ISSNLinking>
      </MedlineJournalInfo>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C537778">Antisynthetase syndrome</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009220" MajorTopicYN="Y">Myositis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antisynthetase syndrome</Keyword>
        <Keyword MajorTopicYN="N">Overlap syndromes</Keyword>
        <Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword>
        <Keyword MajorTopicYN="N">Sjögren’s syndrome</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>5</Hour>
          <Minute>23</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35369881</ArticleId>
        <ArticleId IdType="pmc">PMC8978378</ArticleId>
        <ArticleId IdType="doi">10.1186/s13256-022-03353-3</ArticleId>
        <ArticleId IdType="pii">10.1186/s13256-022-03353-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Maddison PJ. Overlap syndromes and mixed connective tissue disease. Curr Opin Rheumatol. 1991;3(6):995–1000. doi: 10.1097/00002281-199112000-00016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00002281-199112000-00016</ArticleId>
            <ArticleId IdType="pubmed">1772755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rose NR. Autoimmune diseases: tracing the shared threads. Hosp Pract (1995). 1997;32(4):147–54. doi: 10.1080/21548331.1997.11443469.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21548331.1997.11443469</ArticleId>
            <ArticleId IdType="pubmed">9109812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M, et al.  Overlap connective tissue disease syndromes. Autoimmun Rev. 2013;12(3):363–373. doi: 10.1016/j.autrev.2012.06.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2012.06.004</ArticleId>
            <ArticleId IdType="pubmed">22743033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M, et al.  Overlap connective tissue disease syndromes. Autoimmun Rev. 2013;12:363. doi: 10.1016/j.autrev.2012.06.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2012.06.004</ArticleId>
            <ArticleId IdType="pubmed">22743033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meyer A, Lefevre G, Bierry G, Duval A, Ottaviani S, Meyer O, et al.  In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis. Medicine (Baltimore). 2015;94(20):e523. doi: 10.1097/MD.0000000000000523.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000000523</ArticleId>
            <ArticleId IdType="pmc">PMC4602869</ArticleId>
            <ArticleId IdType="pubmed">25997035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi: 10.1002/art.27584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.27584</ArticleId>
            <ArticleId IdType="pubmed">20872595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138(6):1464–1474. doi: 10.1378/chest.10-0180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.10-0180</ArticleId>
            <ArticleId IdType="pubmed">21138882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011;37(1):100–9. doi: 10.1590/S1806-37132011000100015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1806-37132011000100015</ArticleId>
            <ArticleId IdType="pmc">PMC3676869</ArticleId>
            <ArticleId IdType="pubmed">21390438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al.  Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–558. doi: 10.1136/ard.61.6.554.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/ard.61.6.554</ArticleId>
            <ArticleId IdType="pmc">PMC1754137</ArticleId>
            <ArticleId IdType="pubmed">12006334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Care Res. 2009;61(11):1472–1483. doi: 10.1002/art.24827.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.24827</ArticleId>
            <ArticleId IdType="pmc">PMC2859449</ArticleId>
            <ArticleId IdType="pubmed">19877103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum. 2009;61(11):1472–1483. doi: 10.1002/art.24827.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.24827</ArticleId>
            <ArticleId IdType="pmc">PMC2859449</ArticleId>
            <ArticleId IdType="pubmed">19877103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wasicek CA, Reichlin M, Montes M, Raghu G. Polymyositis and interstitial lung disease in a patient with anti-Jo1 prototype. Am J Med. 1984;76(3):538–544. doi: 10.1016/0002-9343(84)90677-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0002-9343(84)90677-6</ArticleId>
            <ArticleId IdType="pubmed">6702878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chatterjee S, Prayson R, Farver C. Antisynthetase syndrome: not just an inflammatory myopathy. Cleve Clin J Med. 2013;80(10):655–666. doi: 10.3949/ccjm.80a.12171.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3949/ccjm.80a.12171</ArticleId>
            <ArticleId IdType="pubmed">24085811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katzap E, Barilla-LaBarca M-L, Marder G. Antisynthetase syndrome. Curr Rheumatol Rep. 2011;13(3):175–181. doi: 10.1007/s11926-011-0176-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11926-011-0176-8</ArticleId>
            <ArticleId IdType="pubmed">21455765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt WA, Wetzel W, Friedländer R, Lange R, Sörensen HF, Lichey HJ, et al.  Clinical and serological aspects of patients with anti-Jo-1 antibodies—an evolving spectrum of disease manifestations. Clin Rheumatol. 2000;19(5):371–377. doi: 10.1007/s100670070030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s100670070030</ArticleId>
            <ArticleId IdType="pubmed">11055826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zamora AC, Hoskote SS, Abascal-Bolado B, White D, Cox CW, Ryu JH, et al.  Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome. Respir Med. 2016;118:39–45. doi: 10.1016/j.rmed.2016.07.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2016.07.009</ArticleId>
            <ArticleId IdType="pubmed">27578469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plastiras SC, Soliotis FC, Vlachoyiannopoulos P, Tzelepis GE. Interstitial lung disease in a patient with antisynthetase syndrome and no myositis. Clin Rheumatol. 2007;26(1):108–111. doi: 10.1007/s10067-005-0111-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-005-0111-3</ArticleId>
            <ArticleId IdType="pubmed">16328094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meyer KC. Diagnosis and management of interstitial lung disease. Transl Respir Med. 2014 doi: 10.1186/2213-0802-2-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/2213-0802-2-4</ArticleId>
            <ArticleId IdType="pmc">PMC4215823</ArticleId>
            <ArticleId IdType="pubmed">25505696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solomon J, Swigris JJ, Brown KK. Doença pulmonar intersticial relacionada a miosite e a síndrome antissintetase. J Bras Pneumol. 2011;37(1):100–109. doi: 10.1590/S1806-37132011000100015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1806-37132011000100015</ArticleId>
            <ArticleId IdType="pmc">PMC3676869</ArticleId>
            <ArticleId IdType="pubmed">21390438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mielnik P, Wiesik-Szewczyk E, Olesinska M, Chwalinska-Sadowska H, Zabek J. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies. Autoimmunity. 2006;39(3):243–247. doi: 10.1080/08916930600623767.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08916930600623767</ArticleId>
            <ArticleId IdType="pubmed">16769658</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
